What are the common signs and symptoms of perimenopause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Common Signs and Symptoms of Perimenopause

Perimenopause presents with a constellation of symptoms that extend far beyond hot flashes, including menstrual irregularities, vasomotor symptoms, sleep disturbances, mood changes, cognitive complaints, and joint pain—symptoms that can begin years before the final menstrual period and persist unpredictably.

Vasomotor Symptoms (VMS)

Hot flashes and night sweats are the hallmark symptoms of perimenopause, though they may not appear until later in the transition 1. Hot flashes typically:

  • Begin as sudden heat sensation centered on the upper chest and face
  • Last 2-4 minutes when moderate to severe
  • Become rapidly generalized throughout the body
  • Are associated with profuse perspiration, palpitations, or anxiety
  • Can be triggered by spicy food or alcohol 1

Night sweats represent vasomotor instability during sleep and may involve different physiological mechanisms than daytime hot flashes 1. These nocturnal symptoms are more common during the first 4 hours of sleep and directly correlate with sleep disruption 1.

Menstrual Changes

Menstrual cycle irregularities are often the first sign of perimenopause, occurring 4-8 years before the final menstrual period 2. Women initially experience changes in menstrual regularity before progressing to more noticeable vasomotor symptoms 2.

Sleep Disturbances

Sleep problems in perimenopause involve:

  • Increased episodes of waking after sleep-onset
  • Decreased perceived sleep efficiency
  • Direct correlation between nocturnal VMS and sleep disruption 1

Aging itself contributes to sleep disturbances, making it difficult to attribute all sleep problems solely to hormonal changes 1.

Mood and Cognitive Symptoms

Recent longitudinal studies now support a clear association between the menopause transition and mood disturbances, contradicting earlier uncertain conclusions 1. Perimenopausal women experience:

  • Depressed mood and major depressive episodes
  • Anxiety and panic attacks
  • Irritability
  • Mood swings 1, 3

Women have an increased risk of developing mood disorders during perimenopause regardless of prior psychiatric history 2. These symptoms tend to peak during perimenopause and typically improve after menopause 2.

Cognitive complaints include:

  • "Brain fog" (difficulty concentrating)
  • Memory fluctuations
  • Cognitive disruption 4, 3, 5

Genitourinary Symptoms

While genitourinary syndrome of menopause (GSM) most often presents in late postmenopause 1, some women begin experiencing:

  • Vaginal dryness
  • Dyspareunia (painful intercourse)
  • Urinary symptoms (dysuria, frequency) 1, 5

Musculoskeletal and Physical Symptoms

Additional common symptoms include:

  • Joint pain (arthralgias) 1, 6
  • Headaches 4
  • Palpitations 1, 3
  • Breast swelling and mastalgia 4, 3

Other Symptoms

The evidence supports associations with:

  • Fatigue (very common across all life stages) 4
  • Loss of libido 1
  • Skin dryness 1
  • Vertigo 3

It remains less clear whether anxiety, irritability, depression, palpitations, skin dryness, loss of libido, and fatigue can be definitively attributed to menopause versus other concurrent life factors 1.

Critical Clinical Pitfalls

"Not feeling like myself anymore" is a common presentation where women experience symptoms years before menopause with still-adequate estrogen levels 3. In one online study, 20% of women in the menopausal transition reported unexplained symptoms that caused fears of serious illness, leading to extensive medical work-ups when perimenopause was not considered 3.

Symptoms last much longer than previously thought: Women affected in early perimenopause experience vasomotor symptoms for a median of 11.8 years, while those whose VMS started only after menopause had shorter duration (median 3.4 years) 3.

Differential Diagnosis Considerations

Exclude other causes of hot flashes when clinically indicated 7:

  • Hyperthyroidism
  • Pheochromocytoma
  • Carcinoid syndrome
  • Panic disorder
  • Diabetes
  • Medication side effects (antiestrogens, selective estrogen receptor modulators)

Universal Symptoms Across Life Stages

Notably, fatigue, headache, anxiety, and brain fog occur at high rates across premenopausal, perimenopausal, and menopausal stages 4. This finding emphasizes that limiting focus solely to vasomotor symptoms neglects a large proportion of overall symptom burden 4.

References

Guideline

treatment of symptoms of the menopause: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Research

Evaluating tools for assessing mental health disorders in perimenopausal women.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026

Research

[What is new on peri- and postmenopause?].

Deutsche medizinische Wochenschrift (1946), 2024

Research

Management of perimenopausal and menopausal symptoms.

BMJ (Clinical research ed.), 2023

Research

A systematic review and critical appraisal of menopause guidelines.

BMJ sexual & reproductive health, 2024

Guideline

american association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Related Questions

What laboratory tests should be ordered for a patient with perimenopause experiencing vasomotor symptoms?
Which laboratory tests are recommended for a woman in her late 40s to early 50s presenting with symptoms suggestive of perimenopause?
How should a perimenopausal woman manage hot flashes, vaginal dryness, and decreased sexual desire?
How does ACOG define and diagnose perimenopause?
At age 59, after a hysterectomy performed years ago, could I be experiencing menopause?
What is the appropriate method to transition a patient on Adderall (mixed amphetamine salts) 30 mg immediate‑release twice daily to Vyvanse (lisdexamfetamine)?
In a 6 ft 5 in, 318 lb Black male with mixed connective‑tissue disease, borderline elevated creatinine, eGFR >60 mL/min/1.73 m², intermittent CK elevations, mildly elevated CRP, variable ESR, positive ANA with speckled pattern, high‑titer RNP and anti‑Ro antibodies, negative anti‑Jo‑1, and proximal muscle weakness with a normal EMG, what is the most likely type of inflammatory myopathy (polymyositis, dermatomyositis, necrotizing myopathy, or overlap myositis) and what is the expected prognosis?
When combining ketorolac (Toradol) with opioids, when should the ketorolac be administered?
What Vyvanse (lisdexamfetamine) dose is equivalent to an adult patient taking Adderall (amphetamine) immediate‑release 30 mg twice daily, given the FDA‑approved maximum daily dose of Adderall IR is 40 mg?
I am a 6‑ft‑5‑in, 318‑lb Black male with probable mixed connective tissue disease, modestly elevated creatinine, normal estimated glomerular filtration rate, mildly elevated creatine kinase, low erythrocyte sedimentation rate and C‑reactive protein, positive speckled antinuclear antibody with high anti‑RNP, negative anti‑Jo‑1, normal electromyography, and a cardiac work‑up showing only a transient abnormal ECG but normal troponin trend and a pending stress test; what specific type of inflammatory myopathy (myositis) am I most likely to have, what is the expected prognosis, and should I continue regular physical and occupational therapy?
What is the recommended way to discontinue latuda (lurasidone) after 10 months of use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.